TABLE 1.
The top 20 enriched KEGG pathways.
| Pathway | Enrichment factor | Q value | Gene name |
| Arginine biosynthesis | 8.59 | 0.42 | GLUL, ASS1, ASL |
| Small cell lung cancer | 60.11 | 1.00 | MAX |
| Alanine, aspartate and glutamate metabolism | 5.01 | 1.00 | ASS1, ASL, GLUL |
| Cytokine-cytokine receptor interaction | 2.36 | 1.00 | IL12R2, IL10, TNFRSF25, TNFRSF6B, TNFSF13B, AMHR2, IL1R1 |
| Nicotinate and nicotinamide metabolism | 3.76 | 1.00 | NT5E, NADK |
| Transcriptional misregulation in cancer | 8.59 | 1.00 | MAX |
| SNARE interactions in vesicular transport | 3.44 | 1.00 | STX5, STX3 |
| Cardiac muscle contraction | 2.50 | 1.00 | ATP1B, Gallus_gallus_newGene_1, Gallus_gallus_newGene_5066 |
| Other types of O-glycan biosynthesis | 3.34 | 1.00 | FNG, POFUT |
| Biosynthesis of amino acids | 2.40 | 1.00 | ASS1, ASL, GLUL |
| Adherens junction | 2.23 | 1.00 | SRC, TGFBR2, PVRL4 |
| Intestinal immune network for IgA production | 2.80 | 1.00 | IL-10, TNFSF13B |
| Pathways in cancer | 5.46 | 1.00 | MAX |
| Taurine and hypotaurine metabolism | 5.46 | 1.00 | GGT1 |
| Ascorbate and aldarate metabolism | 5.46 | 1.00 | UGT |
| Glutathione metabolism | 2.50 | 1.00 | GGT1, GPX |
| Glycosphingolipid biosynthesis – ganglio series | 4.62 | 1.00 | SIAT9 |
| Cell adhesion molecules (CAMs) | 1.73 | 1.00 | PDCD1, CLDN, SELPLG, SELE |
| Amino sugar and nucleotide sugar metabolism | 2.31 | 1.00 | NANP, CHIA |
| Notch signaling pathway | 2.27 | 1.00 | FNG, CTBP |